- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03194191
Pregnancy With Insomnia: a Trial of Acupuncture (GAS)
Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.
GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.
Studieoversikt
Detaljert beskrivelse
Scientific justification:
- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.
Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.
- To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
- Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.
Population:
The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.
Objectives:
- Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
- Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .
Study design:
- Study Type: Multicentre, Interventional, randomized, 2 parallel groups
- Endpoint Classification: Efficacy Study
- Intervention Model: Parallel Assignment
- Masking: Single blind (patient blinded to intervention)
- Primary Purpose: Treatment
- One acupuncture session weekly for 4 consecutive weeks
Visits:
- Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
- Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
- Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
- End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age > 18 years
- Singleton pregnancy
- Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
- Insomnia Severity Index ≥ 10
- Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
- Patient understanding the study
- Informed consent signed
- Social insurance available at inclusion and until the end of pregnancy
Exclusion Criteria:
- Threatened premature labor
- Small fetus for gestational age
- Pre-eclampsia
- Insomnia starting before pregnancy
- Use of psychotropic drugs before pregnancy
- Use of recreational drugs during pregnancy
- Known psychiatric disorder
- Anticoagulant therapy
- Patient reporting insomnia results from chronic or acute pain
- Obstructive sleep apnea (OSA) requiring treatment
- Patient under antidepressant therapy
- Patient under legal guardianship or deprived of freedom
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
|
The patient will be in a semi recumbent position during needle penetration.
Duration of needle insertion: 30 minutes
|
Sham-komparator: Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
|
The patient will be in a semi recumbent position during needle penetration.
Duration of needle insertion: 30 minutes
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Insomnia severity index (ISI)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Pittsburgh Sleep Quality Index (PSQI)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Hospital Anxiety and Depression Scale (HADS)
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Cumulated dose of each psychotropic medicine
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of any drug.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Cumulated dose of alcohol
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of alcohol.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Cumulated dose of tobacco
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of tobacco.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Cumulated dose of cannabis
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of cannabis.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Cumulated dose of other recreational substances or medicine
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Difference in the frequency of restless leg syndrome
Tidsramme: Inclusion visit and 5 weeks after the first acupuncture session
|
According to the guidelines of the International Restless Legs Syndrome Study Group. The diagnosis of restless leg will rely on the presence of all of the following criteria:
|
Inclusion visit and 5 weeks after the first acupuncture session
|
Perinatal outcome - Gestational age at birth
Tidsramme: At birth
|
The gestational age at birth of the newborn will be recorded.
|
At birth
|
Perinatal outcome - birth weight
Tidsramme: At birth
|
The weight (in gr) at birth of the newborn will be recorded.
|
At birth
|
Perinatal outcome - birth height
Tidsramme: At birth
|
The height (in cm) at birth of the newborn will be recorded.
|
At birth
|
Perinatal outcome - sex
Tidsramme: At birth
|
The sex of the newborn will be recorded.
|
At birth
|
Perinatal outcome - perinatal mortality
Tidsramme: At birth
|
The perinatal mortality will be recorded.
|
At birth
|
Perinatal outcome - five minutes Apgar score
Tidsramme: At birth
|
The five minutes Apgar score will be recorded.
|
At birth
|
Perinatal outcome - cesarean section rate
Tidsramme: At birth.
|
Cesarean section rate will be recorded.
|
At birth.
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Stéphanie Nicolian, Midewife, Assistance Publique - Hôpitaux de Paris
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P150951
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Søvnløshet
-
Ohio State UniversityHar ikke rekruttert ennåInsomni Type; Søvnforstyrrelse
-
SRI InternationalFullført
-
Eisai Inc.Purdue Pharma LPFullført
-
Janssen Research & Development, LLCFullførtInsomni lidelserBelgia, Forente stater, Tyskland, Polen, Japan, Frankrike
-
Woolcock Institute of Medical ResearchRekrutteringKognitiv svikt | Insomni Type; SøvnforstyrrelseAustralia
-
Taipei Veterans General Hospital, TaiwanTaipei Chinese Medical Association, TaiwanUkjentInsomni Type; Søvnforstyrrelse | Perimenopausale kvinnerTaiwan
-
Universidad Antonio de NebrijaFundación para el Fomento de la Investigación Sanitaria y Biomédica de...Påmelding etter invitasjonSøvnløshet | Insomni Type; SøvnforstyrrelseSpania
-
Bod AustraliaWoolcock Institute of Medical ResearchFullførtSøvnløshet | Søvnforstyrrelser | Insomni Type; Søvnforstyrrelse | Søvnløshet, forbigående | Søvnløshet på grunn av angst og frykt | Søvnløshet på grunn av annen psykisk lidelseAustralia